Company Announcements Illumina named Laura Lauman vice president of Marketing in December 2011. She was formerly president of AB SCIEX. In January, Illumina appointed Marc Stapley senior vice president and CFO. Previously, he was senior vice president, Finance, at Pfizer. The Austin Business Journal reported in December 2011 that Thermo Fisher Scientific will hire 150 […]
Fourth-quarter 2011 IBO Life Science Index sales grew 5.2%, 5.0% excluding currency, to $3,599.71 million. Operating profit expanded 4.4% to $829.93 million, but operating margin slipped 30 basis points to 22.7% of revenues. For 2011, Life Science Index sales grew 7.0%, 5.5% on a currency-neutral basis, to $13,047.60 million. Operating profit rose 5.5% to $2,820.89 […]
Washington, DC 2/29/12—Bruker reported in its 10K SEC filing that it has completed its internal investigation of improper payments by Bruker Optics employees to Chinese government-owned enterprises (see IBO 8/15/11). The company found evidence that improper payments were made that did not comply with its policies and standards of conduct. As a result, Bruker terminated […]
Last year, for the first time, analytical and life science instrumentation sales in India exceeded $1 billion. Analytical and life science instrumentation sales in the country are expected to grow in the low double digits in 2012, led by sales of life science instrumentation—which have surpassed separation techniques as the fastest-growing category of analytical techniques […]
In the calendar-year fourth quarter, major, publicly held US instrument companies posted steady growth. In general, US academic and government sales improved from the third quarter but remained slow, according to several companies. The surprise of the quarter was Europe, for which a number of firms reported sales growth. For the eight businesses whose results […]
As discussed in IBO’s August 15, 2011, issue, China’s 12th Five-Year Plan was initiated last year, with the aim of boosting the country’ R&D spending to 2.2% of GDP, compared with 1.8% of GDP in 2010. Details of the specific industry and regional five-year plans continue to be announced, including the funding amounts and goals […]
The Dow Jones Industrial Average traded above 13,000 in February for the first time since April 2008. Market momentum was stimulated by employment growth, manufacturing data, rising consumer sentiment and strong technology earnings. On February 29, fourth-quarter GDP growth was revised up to 3.0% from initial estimates of 2.8%. However, concerns emerged as economic data […]
Private R&D spending on agricultural inputs grew 4.4% from 2009 to 2010, according to the US Department of Agriculture Economic Research Service’s December 2011 report entitled Research Investments and Market Structure in the Food Processing, Agricultural Input and Biofuel Industries Worldwide. The report analyzes worldwide private R&D spending for seven agricultural-input areas, as well as […]
Twelve of the 19 companies in the IBO Laboratory Sales Index reported fourth-quarter earnings before this issue’s publication. Including estimates for companies yet to report, fourth-quarter revenue for the IBO Laboratory Sales Index grew 7.2%, including a loss of 6.9% excluding currency. Operating profit for the Index climbed 16.7%, and operating margin improved 90 basis […]
Below are financial reviews for Oxford Instruments and Analytik Jena, both of which are in IBO’s Lab Instrument Sales Index. Each company experienced strong operating gains. For the fiscal half year ending September 30, 2011, Oxford Instruments’ sales grew 40.5%, 30.0% organically, to £159.1 million ($252.5 million = £0.63 = $1). Acquisitions added 11.8% to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
